✦ LIBER ✦

Immunoediting breast cancer using HER-2/neu pulsed autologous dendritic cell vaccines

✍ Scribed by B.J. Czerniecki; U. Koldovsky; S. Xu; R. Mick; H. Nisenbaum; S. Orel; K. Fox; P. Zhang

Book ID: 116702124
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 130
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2005.11.100

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I vaccine trial using dendritic

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

✍ Lana E Kandalaft, Cheryl L Chiang, Janos Tanyi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 476 KB

Asymptomatic changes in cardiac function

Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu–pulsed dendritic cell vaccines

✍ Susan Bahl; Robert E. Roses; Anupama Sharma; Ursula Koldovsky; Shuwen Xu; Susan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Immunotherapy of murine colon cancer usi

Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines

✍ Shinjiro Yamaguchi; Tomohide Tatsumi; Tetsuo Takehara; Ryotaro Sakamori; Akio Ue 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract ## BACKGROUND. Further optimization of dendritic cell (DC)‐based vaccines is required clinically against advanced stage cancer. Given the broad range of expression levels observed in the recently defined tumor antigen EphA2 in a diverse types of cancers, especially in advanced stage or

Vaccination of fiber-modified adenovirus

Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice

✍ Sas, S; Chan, T; Sami, A; El-Gayed, A; Xiang, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 321 KB

Evaluation of the HER2/neu-derived pepti

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

✍ Elizabeth A. Mittendorf; Catherine Storrer; Craig Shriver; Sathibalan Ponniah; G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Evaluation of the HER2/neu-derived pepti

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

✍ Elizabeth A. Mittendorf; Catherine E. Storrer; Rebecca J. Foley; Katie Harris; Y 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 1 views